Cancer has been one of the leading causes of death in the world. We all saw cancer as a disease that couldn’t be cured, and we all believed that anyone who has cancer might have to face extreme difficulties just to survive. With the advancement of science, we are finally at a stage where we can see light at the end of the tunnel.
There was a remarkable breakthrough in science recently. During this study, a set of 18 patients with rectal cancer were taken and they were given treatment with an immunotherapy drug called Dorstalimab. It was administered by a company called GlaxoSmithKline which also help fund the research. Miraculously cancer vanished in every single one of the patients and the results even surprised the scientists. They conducted different tests in the forms of physical exams, endoscopy, and PET scans/MRI scans, and all of the results were negative. This was the first time any such study had a 100% success rate and we can truly consider this a major scientific breakthrough. This remarkable finding was found by the Memorial Sloan Kettering Cancer Center. If you are interested in going through the study conducted, you can refer to the New England Journal of Medicine.
This immunotherapy treatment enables the blood cells to destroy the cancer cells completely. In a cancer cell, there is a certain element that prevents it from being destroyed. This newfound treatment disables the function of the cancer cells so that they can be destroyed. One of the greatest surprises was that none of the patients suffered any serious side effects.
The researchers are now focusing on conducting these tests on a larger level so that they can get a clearer idea of the medication. This trial is expected to conclude with around 30 patients which will give the researchers a better understanding of their medication. However, the downside of this is that this drug costs around 11 000 USD per dose and it had to be administered to each patient once in three weeks within the course of the three months. At the moment this drug seems to be a very costly alternative but we must be thankful for everyone who took part in this research as it certainly is a remarkable finding that may very well change the course of humanity. What was once known as an incurable and deadly disease might as well be an extinct disease in the near future. Let’s end on a hopeful note that there will be further improvements in the field and let us hope that these medications will be affordable and accessible for every patient around the world very soon.
Await further updates on the cure.
